Global Proteomics Strategic Research Report 2023-2030 – U.S. Market is Estimated at $11.5 Billion, While China is Forecast to Grow at 12.8% CAGR

DUBLIN, Dec. 6, 2023 /PRNewswire/ — The “Proteomics – Global Strategic Business Report” report has been added to  ResearchAndMarkets.com’s offering.

Global Proteomics Market to Reach $65.3 Billion by 2030

The global market for Proteomics estimated at US$30.2 Billion in the year 2022, is projected to reach a revised size of US$65.3 Billion by 2030, growing at a CAGR of 10.1% over the analysis period 2022-2030. Reagents, one of the segments analyzed in the report, is projected to record 10% CAGR and reach US$48.2 Billion by the end of the analysis period. Growth in the Instruments segment is estimated at 11% CAGR for the next 8-year period.

Proteomics has emerged as a crucial research tool in the battle against COVID-19. The pressing need for diagnostics and therapeutics for COVID-19 has highlighted the dynamic role of proteomics in gaining insights into the virus and facilitating drug discovery.

Proteomics plays a significant role in enabling the development of potent antiviral agents and improved vaccines against COVID-19. Proteomics labs are actively exploring therapeutic options and diagnostic development related to the virus.

Proteomics encompasses the study of proteins, proteome, and their data types and characteristics. It has its genesis in important milestones and has various applications in fields such as medicine, biology, and drug discovery. The global proteomics market is competitive, with various key competitors vying for market share, and their competitive presence varies from strong to niche or trivial.

Despite its promising role, proteomics faces challenges such as sparse and difficult-to-measure data, the need to democratize proteomics, absence of high-profile projects to stimulate interest, creating novel experimental design, lack of commercialization of high throughput techniques, and a lack of necessary technical skillset.

 The U.S. Market is Estimated at $11.5 Billion, While China is Forecast to Grow at 12.8% CAGR

The Proteomics market in the U.S. is estimated at US$11.5 Billion in the year 2022. China, the world’s second largest economy, is forecast to reach a projected market size of US$6.5 Billion by the year 2030 trailing a CAGR of 12.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.9% and 9.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 9.7% CAGR.

What`s New?

Special discussions on the global economic climate and market sentimentCoverage on global competitiveness and key competitor percentage market sharesMarket presence analysis across multiple geographies – Strong/Active/Niche/TrivialOnline interactive peer-to-peer collaborative bespoke updatesAccess to digital archives and trademarked research platformComplimentary updates for one yearAccess to curated YouTube video transcripts of market sentiments shared by CEOs, domain experts and market influencers via interviews, podcasts, press statements and event keynotes

MARKET TRENDS & DRIVERS

Proteomics Profiling to Expedite Drug DiscoveryOther Applications of Proteomics in Drug DiscoveryNew Proteomics Technique to Aid Drug Screening & Biomarker DiscoveryDiseases as a Major Cause of Deaths Worldwide Brings to Fore the Growing Importance of New Breakthroughs in Proteomics-Based Technologies: Top Global Causes of Death (In Millions) by Type of Disease for the Years 2000 and 2019Global Drug Discovery Market by Segment: 2020Growing Interest in Personalized Medicine to Drive Market GrowthGlobal Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025Oncology: A Key Focus Area for ProteomicsGlobal Breakdown of Total Number of Cancer Cases by Type: 2020Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040Proteomic Approaches Gain Prominence in Cancer Drug DiscoveryProteomics Technologies Used in Cancer Drug Discovery and DevelopmentRole of Proteomics in Oncology Biomarker DiscoveryList of FDA-approved Protein Biomarkers for CancerAdvancements in Proteomics Bring Biomarkers into LimelightDifferent Types of MS-Based Proteomic Discovery Techniques for BiomarkersAffinity-Reagent-Array-Based TechniquesAffinity-and-Antibody-Based MS TechniquesCE-MS Technology: An Emerging Technology for Discovery of BiomarkersProtein Microarrays: A Novel Tool for the Development of PharmaceuticalsProtein Microarray FormatsNew Technologies Expand Application of ProteomicsDIA Technique for Protein DiscoveryAI and Machine Learning Address Shortcomings of Traditional Equipment in Effectively Identifying Protein PatternsBioinformatics Tools along with Proteomics Accelerate the Process of Pathway PredictionMap of COVID-19 and Human Protein Interactions Reveals Drug TargetsSingle-Cell Proteomics Offers a Better Understanding of Cellular IdentityMetalloproteomics: A Rapidly Evolving FieldPost-translational Modification of Proteins Increases Functional Diversity of ProteomePharmacoproteomics Holds Significant Prospects in Precision MedicineIncreasing Prominence of Nanoproteomics Widens OpportunitiesGlobal Proteomics Sample Preparation MarketChallenges FacedManagement of Data in Proteomics Research Poses a Big challengeRole of Contract Research Organizations to Increase in Proteomics

FOCUS ON SELECT PLAYERS (Total 178 Featured)

Active Motif, Inc.20/20 Genesystems, Inc.BG Medicine, Inc.BGI-ShenzhenBiodesix, Inc.Abbiotec LLCBioChain Institute, Inc.Arbor Vita CorporationBiomosaics, Inc.Advansta Inc.AYOXXA Biosystems GmbHAKESOgen, Inc.BiognosysBiorbytBioAnalyte

For more information about this report visit https://www.researchandmarkets.com/r/ltbh3e

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo – https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/global-proteomics-strategic-research-report-2023-2030—us-market-is-estimated-at-11-5-billion-while-china-is-forecast-to-grow-at-12-8-cagr-302007989.html

SOURCE Research and Markets